[go: up one dir, main page]

ES2177583T3 - Nuevo compuesto tetraciclico. - Google Patents

Nuevo compuesto tetraciclico.

Info

Publication number
ES2177583T3
ES2177583T3 ES94927786T ES94927786T ES2177583T3 ES 2177583 T3 ES2177583 T3 ES 2177583T3 ES 94927786 T ES94927786 T ES 94927786T ES 94927786 T ES94927786 T ES 94927786T ES 2177583 T3 ES2177583 T3 ES 2177583T3
Authority
ES
Spain
Prior art keywords
tetraciclic
compound
new
immunosuppressant
remedy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94927786T
Other languages
English (en)
Inventor
Fumio Suzuki
Yoshisuke Nakasato
Hiroshi Tumuki
Soichiro Sato
Tadafumi Tamura
Hiroshi Nakajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of ES2177583T3 publication Critical patent/ES2177583T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

UN COMPUESTO TETRACICLICO NUEVO REPRESENTADO POR LA FORMULA GENERAL (I) O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DEL MISMO. POSEE UNA ACTIVIDAD INMUNOSUPRESIVA POTENTE Y ES UTIL COMO UN INMUNOSUPRESANTE Y UN REMEDIO PARA LAS ENFERMEDADES AUTOINMUNES.
ES94927786T 1993-09-28 1994-09-28 Nuevo compuesto tetraciclico. Expired - Lifetime ES2177583T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24136093 1993-09-28

Publications (1)

Publication Number Publication Date
ES2177583T3 true ES2177583T3 (es) 2002-12-16

Family

ID=17073136

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94927786T Expired - Lifetime ES2177583T3 (es) 1993-09-28 1994-09-28 Nuevo compuesto tetraciclico.

Country Status (8)

Country Link
US (1) US5646283A (es)
EP (1) EP0721942B1 (es)
AT (1) ATE218551T1 (es)
AU (1) AU7707094A (es)
CA (1) CA2150235A1 (es)
DE (1) DE69430752T2 (es)
ES (1) ES2177583T3 (es)
WO (1) WO1995009153A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0950054A1 (en) * 1996-09-23 1999-10-20 Rutgers, The State University Of New Jersey Substituted heterocycles as anti-tumor agents
US6841561B1 (en) 1999-10-01 2005-01-11 Institute Of Molecular And Cell Biology Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases
JP2003510352A (ja) * 1999-10-01 2003-03-18 インスティチュート オブ モレキュラー アンド セル バイオロジー ウイルス媒介性疾病の治療用化合物
US6740650B2 (en) 1999-10-29 2004-05-25 Rutgers, The State University Of New Jersey Heterocyclic cytotoxic agents
WO2003047505A2 (en) * 2001-11-14 2003-06-12 Rutgers, The State University Topoisomerase poison agents
AU2002352708A1 (en) 2001-11-14 2003-05-26 Edmond J. Lavoie Cytotoxic agents
EP2286812A1 (en) * 2001-11-14 2011-02-23 Rutgers, The State University Solubilized topoisomerase poisons
MXPA04004607A (es) * 2001-11-14 2004-09-10 Univ Rutgers Agentes de venenos de topoisomerasa solubilizados.
US6992088B2 (en) * 2002-08-09 2006-01-31 Rutgers, The State University Of New Jersey Nitro and amino substituted heterocycles as topoisomerase I targeting agents
AU2003265406A1 (en) * 2002-08-09 2004-02-25 Edmond J. Lavoie Nitro and amino substituted topoisomerase agents
WO2004014906A2 (en) * 2002-08-09 2004-02-19 Rutgers, The State University Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
JP4774212B2 (ja) * 2002-11-12 2011-09-14 ラトガーズ、ザ・ステイト・ユニバーシテイ・オブ・ニユー・ジヤージー トポイソメラーゼ−ターゲッティング剤
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
WO2009038731A2 (en) * 2007-09-17 2009-03-26 The Trustees Of Columbia University In The City Of New York Synthesis of resveratrol-based natural products
ES2401563T3 (es) 2009-03-06 2013-04-22 Rutgers, The State University Of New Jersey Derivados de metilendioxibenzo [I]fenantridina usados para tratar el cáncer
WO2010127363A1 (en) 2009-05-01 2010-11-04 Rutgers, The State University Of New Jersey Toposiomerase inhibitors
WO2011103442A2 (en) * 2010-02-18 2011-08-25 The Trustees Of Columbia University In The City Of New York Synthesis of the potent immunosuppressant agents dalesconol a and b
US20160287549A1 (en) 2013-11-22 2016-10-06 Genzyme Corporation Novel methods for treating neurodegenerative diseases
WO2017176648A1 (en) 2016-04-04 2017-10-12 Rutgers, The State University Of New Jersey Topoisomerase poisons

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0233661A (ja) * 1988-07-22 1990-02-02 Sharp Corp 住所自動入力機能付文字処理装置
US4918077A (en) * 1989-01-25 1990-04-17 E. I. Du Pont De Nemours & Co., Inc. 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
US5223506A (en) * 1991-06-04 1993-06-29 Glaxo Inc. Cyclic antitumor compounds
WO1993022286A1 (fr) * 1992-04-24 1993-11-11 Kyowa Hakko Kogyo Co., Ltd. Nouveau compose tetracyclique
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents

Also Published As

Publication number Publication date
CA2150235A1 (en) 1995-04-06
WO1995009153A1 (en) 1995-04-06
AU7707094A (en) 1995-04-18
US5646283A (en) 1997-07-08
DE69430752T2 (de) 2002-10-17
EP0721942B1 (en) 2002-06-05
EP0721942A4 (en) 1997-03-05
DE69430752D1 (de) 2002-07-11
EP0721942A1 (en) 1996-07-17
ATE218551T1 (de) 2002-06-15

Similar Documents

Publication Publication Date Title
ES2177583T3 (es) Nuevo compuesto tetraciclico.
PT705833E (pt) Derivado de dc-89
AU7237294A (en) Remedy for parkinson's disease
AU1282495A (en) Anthranilic acid derivative
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
ATE136900T1 (de) Prolinderivat von rapamycin, seine herstellung und verwendung
ATE192927T1 (de) Neue cephem-derivate
PT1122253E (pt) Derivados de quinazolinona
ATE190308T1 (de) Epoxycyclohexendionderivat
FI952420A0 (fi) Glukopyranosidibentsotiofeenit
KR970009570B1 (en) Intermediates of aminobenzoic acid
TW334428B (en) Novel benzodiazepine derivatives
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
EP0924204A4 (en) 2-PHENYLMORPHOLIN-5-ON DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
KR960702307A (ko) 항불안약 (anxiolytic agent)
DE69611148D1 (de) Pyrrolo(4,3,2-de)chinolin-Derivat
DE69303847D1 (de) Indolderivate
ATE187331T1 (de) Benzopyranderivate
ES2061182T3 (es) 2-fluoroneplanocina a y su fabricacion.